Androgens and male physiology the syndrome of 5α-reductase-2 deficiency
Introduction
Male sexual development in the mammalian system involves three sequential processes. The first step is establishment of genetic sex by the presence of 46XY sex chromosomes, a process completed at the time of fertilization of the ovum. The second step is differentiation of the indifferent gonad to a testis. The process of testicular differentiation involves the SRY gene located on the Y chromosome as well as multiple genes located on autosomal chromosomes. The third step is translation of the gonadal sex to phenotypic sex, i.e. the formation of internal and external genitalia. Both testosterone and its 5α reduced metabolite, DHT, play critical roles in this process.
The importance of both androgens in male sexual differentiation and development, and in determining male gender identity will be discussed by reviewing the clinical syndrome of 5α-reductase-2 deficiency.
Section snippets
5α-Reductase isozymes
Steroid 5α-reductase isozymes are located in the microsomes of the cell. These isozymes convert testosterone to DHT, a more potent androgen. They are NADPH-dependent enzymes that reduce the double bond at the four to five position in C19 steroids as well as C21 steroids. Both testosterone and DHT bind to the same intracellular androgen receptor, which is a member of the nuclear steroid/thyroid hormone receptor superfamily, to regulate target gene expression (Beato, 1989). Although testosterone
Clinical presentation
The clinical syndrome of 5α-reductase deficiency was first described, clinically and biochemically, in studies of 24 affected subjects from a large Dominican kindred (Imperato-McGinley et al., 1974), and in two siblings from Dallas (Walsh et al., 1974). Subsequently a large cohort in New Guinea (Imperato-McGinley et al., 1991) and another in Turkey were described (Akgun et al., 1986, Can et al., 1998, Imperato-McGinley et al., 1987) as well as many other cases worldwide [see recent review (Zhu
Biochemical features of 5α-reductase-2 deficiency
Over the years, the biochemical features of this syndrome have been well defined (see recent reviews Imperato-McGinley, 1996, Zhu et al., 1998). These include: (a) normal to elevated levels of plasma testosterone; (b) decreased levels of plasma DHT; (c) an increased testosterone to DHT ratio at baseline and/or following hCG stimulation; (d) decreased conversion of testosterone to dihydrotestosterone (DHT) in vivo; (e) normal metabolic clearance rates of testosterone and DHT; (f) decreased
Defects in the 5α-reductase-2 gene
The first identified genetic defect of 5α-reductase deficiency was carried out in male pseudohermaphrodites from our New Guinean kindred (Andersson et al., 1991). To date, over 33 mutations in the 5α-reductase-2 gene (Wilson et al., 1993, Nordenskjold et al., 1998, Vilchis et al., 2000, Zhu et al., 1998 and our unpublished data) have been identified, including mutations in the three largest kindreds of male pseudohermaphrodites with 5α-reductase-2 deficiency in the world—the Dominican, New
Gender identity change
Gender identity change from female to male has been demonstrated in subjects with 5α-reductase-2 deficiency from different areas of the world (see recent review Imperato-McGinley and Zhu, 2002). These subjects demonstrate that exposure of the brain to androgen (testosterone) in utero, during the early postnatal period, and at puberty, appears to have a greater impact in determining male gender identity than does sex of rearing and sociocultural influences. Normally the sex of rearing and
Acknowledgements
The studies were supported in part by NIH Grant M01-RR-00047 (General Clinical Research Center) and HD-09421-15.
References (73)
- et al.
Familial male pseudohermaphroditism in a Turkish village due to 5α-reductase deficiency
Am. J. Med.
(1986) Gene regulation by steroid hormones
Cell
(1989)- et al.
Evidence for a role of glucuronosyltransferase in the regulation of androgen action in the human prostatic cancer cell line LNCaP
J. Steroid Biochem. Mol. Biol.
(1996) Comparison of nuclear 5 alpha-reductase activities in the stromal and epithelial fractions of human prostatic tissue
J. Steroid Biochem.
(1987)- et al.
Male pseudohermaphroditism: complexities of male sexual development
Am. J. Med.
(1976) - et al.
Male pseudohermaphroditism secondary to 5α-reductase deficiency: a model for the role of androgens in both the development of the male phenotype and the evolution of a male gender identity
J. Steroid Biochem. Mol. Biol.
(1979) - et al.
The heterogeneity of delta 4-3-ketosteroid reductase (5α)
J. Biol. Chem.
(1960) - et al.
Diminished 5alpha-reductase activity in extracts of fibroblasts cultured from patients with familial incomplete male pseudohermaphroditism, type 2
J. Biol. Chem.
(1975) - et al.
Steroid 5alpha-reductase in cultured human fibroblasts. Biochemical and genetic evidence for two distinct enzyme activities
J. Biol. Chem.
(1976) - et al.
Male pseudohermaphroditism due to steroid 5α-reductase deficiency
Am. J. Med.
(1977)
Cell type specific expression of steroid 5 alpha-reductase 2
J. Urol.
Comparison of testosterone metabolism in benign prostatic hyperplasia and human prostate cancer cell lines in vitro
J. Steroid Biochem. Mol. Biol.
Characterization of Chinese hamster ovary cell lines expressing human steroid 5 alpha-reductase isozymes
J. Biol. Chem.
Natural potent androgens: lessons from human genetic models. Baillieres
Clin. Endocrinol. Metab.
Structural and biochemical properties of cloned and expressed human and rat steroid 5α-reductases
Proc. Natl. Acad. Sci. USA
Deletion of steroid 5α-reductase-2 gene in male pseudohermaphroditism
Nature
Kinetic parameters of 5α-reductase activity in stroma and epithelium of normal, hyperplastic, and carcinomatous human prostates
J. Clin. Endocrinol. Metab.
Dihydrotestosterone regulation of semen in male pseudohermaphrodites with 5 alpha-reductase-2 deficiency
J. Clin. Endocrinol. Metab.
5α-Reductase-2 gene mutation in the Dominican Republic
J. Clin. Endocrinol. Metab.
The identification of 5α-reductase-2 and 17β -hydroxysteroid dehydrogenase-3 gene defects in male pseudohermaphrodites from a Turkish kindred
J. Clin. Endocrinol. Metab.
LH pulsatility in subjects with 5α-reductase deficiency and decreased DHT production
J. Clin. Endocrinol. Metab.
Product replacement therapy in steroid 5α-reductase deficiency
Ann. Genet.
Potential fertility in incomplete male pseudohermaphroditism type 2
Rev. Invest. Clin.
Variable expression of 5 alpha-reductase deficiency: presentation with male phenotype in a child of Greek origin
J. Clin. Endocrinol. Metab.
5alpha-reductase and 17beta-hydroxysteroid dehydrogenase expression in epithelial cells from hyperplastic and malignant human prostate
Int. J. Cancer
Immunocytochemical localization of human 5 alpha-reductase 2 with polyclonal antibodies in androgen target and non-target human tissues
J. Histochem. Cytochem.
Immunohistochemical evidence for differential distribution of 5 alpha-reductase isoenzymes in human skin
Br. J. Dermatol.
Finasteride: a slow-binding 5 alpha-reductase inhibitor
Biochemistry
Disorders of sexual differentiation
Male pseudohermaphroditism
5 alpha-reductase-2 deficiency
Curr. Ther. Endocrinol. Metab.
Why does a pseudohermaphrodite want to be a man
New Engl. J. Med.
Steroid 5α-reductase deficiency in man: an inherited form of male pseudohermaphroditism
Science
Androgens and the evolution of male-gender identity among male pseudohermaphrodites with 5α-reductase deficiency
New Engl. J. Med.
Steroid 5α-reductase deficiency in a 65-year old male pseudohermaphrodite: the natural history, ultrastructure of the testes and evidence for inherited enzyme heterogeneity
J. Clin. Endocrinol. Metab.
Cited by (242)
The impact of genetic steroid disorders on human fertility
2023, Genetic Steroid Disorders: Second EditionAtypical genitalia in the newborn
2023, Genetic Steroid Disorders: Second Edition46 XY disorder of sex development (DSD) due to 5 alpha (SRD5A2) deficiency – Experience from a multidisciplinary Pediatric Gender Clinic
2022, Journal of Pediatric UrologyCitation Excerpt :Preoperative application of DHT cream stimulates tissue growth [26]; since it is not easily available, we have used intramuscular testosterone instead. Inguinal testes may descend into the scrotum as late as puberty [27] We have done an orchidopexy for inguinal gonads (retractile and undescended) electively in 4 cases at the first surgery for several reasons – to preserve fertility, avoid trauma, psychological reasons, parental anxiety and to limit surgical dissection during urethroplasty. In large UGS remnants [26], the mucosa was removed, and cavity obliterated during the first stage.